3D Printed Drugs Market Share & Growth | Report 2027

3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Dosage Forms (Tablets, Capsules, Multi Drug Implant, Nanoparticles, Solutions, Others); Technology (Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing, Fused Deposition Modeling, Powder Bed Printing, Stereolithography (SLA), Semi Solid Extrusion (SSE)), and Geography

Publication Month : Apr 2020

  • Report Code : TIPRE00010199
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 175
Inquire Before Buy

PRICING

$4550

$2730

The 3D printed drugs marketwas valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.

3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact. The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs.The global 3D printed drugs market is driven by factors such asincreasing adoption of personalized drugs. Additionally, growing research and development activities,coupled with increasing prevalence of dysphagia,is also anticipated to drive the 3D market growth during the forecast period. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market. The developing healthcare infrastructure and increasing awareness regarding 3D printing in pharmaceuticals  generate lucrative opportunities for the growth of the market.

Lucrative Regional 3D Printed Drugs Markets



Lucrative Regional 3D Printed Drugs Markets
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities


Market Insights

Increasing Adoption of Personalized Drugs

Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA approved molecular entities in 2005; whereas, in 2016, they accounted for more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, and expect to increase their investment by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development over the coming five years.

3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms. Through this breakthrough method of manufacturing and its fast-melt capabilities, there is an ability to overcome several obstacles, thereby contributing to better patient outcomes in the solid dose market. For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.

Dosage Form-BasedInsights

Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. In 2019, thetabletssegment held the largest share of the market, and it is further expected to register the highest CAGR in the market during the forecast period. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years.

3D Printed Drugs Market, by Dosage Form– 2019 and 2027



3D Printed Drugs Market, by Dosage Form– 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Technology-BasedInsights

Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). The zip dose technology segmentheld the largest share of the market; moreover, it is expected to register the highest CAGR during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

3D Printed Drugs Market: Strategic Insights

3d-printed-drugs-market
Market Size Value inUS$ 28.52 Million in 2019
Market Size Value byUS$ 57.03Million by 2027
Growth rateCAGR of 9.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and FDA approvalsis a commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand as the strategy allows them to expand their product portfolios.

The 3D printed drugs marketplayers also adopt the strategy ofcollaborations, which enables them enlarge their global customer base,alongside helping them maintain their brand names.

3D Printed Drugs Market – By Dosage Forms

  • Tablets
  • Capsules
  • Multi Drug Implants
  • Nanoparticles
  • Solutions
  • Others

3D Printed Drugs Market – By Technology

  • Inkjet Printing
  • Direct Write
  • Zip Dose
  • Thermal Inkjet Printing
  • Fused Deposition Modeling
  • Powder Bed Printing
  • Stereolithography (SLA)
  • Semi Solid Extrusion (SSE)

3D Printed DrugsMarket– By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America

    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • APRECIA PHARMACEUTICALS, LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC.
  • ASTRAZENECA
  • Tvasta
  • Merck KGGA
  • Terumo Corporation
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Dosage Forms ; Technology , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

Frequently Asked Questions


What is 3D Printed Drug?

3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.

What are the driving factors for the 3D printed drugs market across the globe?

Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines

Who are the major players in the 3D printing drugs market?

Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global 3D Printed Drugs Market – By Dosage Forms

1.3.2 Global 3D Printed Drugs Market – By Technology

1.3.3 Global 3D Printed Drugs Market – By Geography

2. 3D Printed Drugs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global 3D Printed Drugs Market – Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America– PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East & Africa– PEST Analysis

4.2.5 South and Central America – PEST Analysis

5. Global 3D Printed Drugs market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Adoption of Personalized Drugs

5.1.2 Increasing Prevalence of Dysphagia

5.2 Market Restraints

5.2.1 Usage of 3D Printing to Develop Illegal Drugs

5.3 Market Opportunities

5.3.1 Rising Awareness About the 3D Printing Technology

5.4 Future Trends

5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes

5.5 Impact analysis

6. 3D Printed Drugs Market– Global Analysis

6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis

6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. 3D Printed Drugs Market Analysis – By Dosage Forms

7.1 Overview

7.2 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035, (%)

7.3 Tablets

7.3.1 Overview

7.3.2 Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2027 (US$ Thousands)

7.3.3 Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

7.4 Capsules

7.4.1 Overview

7.4.2 Capsules: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

7.5 Multi Drug Implant

7.5.1 Overview

7.5.2 Multi Drug Implant: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

7.6 Nanoparticles

7.6.1 Overview

7.6.2 Nanoparticles: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

7.7 Solutions

7.7.1 Overview

7.7.2 Solutions: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

7.8 Other Dosage Forms

7.8.1 Overview

7.8.2 Other Dosage Forms: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

8. 3D Printed Drugs Market Analysis – By Technology

8.1 Overview

8.2 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)

8.3 Inkjet Printing

8.3.1 Overview

8.3.2 Inkjet Printing: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

8.4 Direct Write

8.4.1 Overview

8.4.2 Direct Write: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

8.5 Zip Dose

8.5.1 Overview

8.5.2 Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2027 (US$ Thousands)

8.5.3 Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

8.6 Thermal Inkjet Printing

8.6.1 Overview

8.6.2 Thermal Inkjet: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

8.7 Fused Deposition Modelling

8.7.1 Overview

8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

8.8 Powder Bed Printing

8.8.1 Overview

8.8.2 Powder Bed Printing: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

8.9 Stereolithography (SLA)

8.9.1 Overview

8.9.2 Stereolithography (SLA): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

8.10 Semi Solid Extrusion (SSE)

8.10.1 Overview

8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

9. 3D Printed Drugs Market – Geographic Analysis

9.1 North America: 3D Printed Drugs Market

9.1.1 Overview

9.1.2 North America: 3D Printed Drugs Market – Revenue and Forecast to 2027 (USD Thousands)

9.1.3 North America: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.1.4 North America: 3D Printed Drugs Market, by Dosage Forms, 2018–2027 (USD Thousands)

9.1.5 North America: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.1.6 North America: 3D Printed Drugs Market, by Technology, 2018–2027 (USD Thousands)

9.1.7 North America: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.1.8 North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)

9.1.9 US: 3D Printed Drugs Market – Revenue and Forecast (USD thousands)

9.1.9.1 US: 3D Printed Drugs Market – Revenue and Forecast to 2027 (USD Thousands)

9.1.9.2 US: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.1.9.3 US: 3D Printed Drugs Market, by Dosage Forms, 2018–2027 (USD Thousands)

9.1.9.4 US: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.1.9.5 US: 3D Printed Drugs Market, by Technology, 2018–2027 (USD Thousands)

9.1.9.6 US: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.1.10 Canada: 3D Printed Drugs Market – Revenue and Forecast (USD Thousands)

9.1.10.1 Canada: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.1.10.2 Canada: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.1.10.3 Canada: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.1.11 Mexico: 3D Printed Drugs Market – Revenue and Forecast (USD thousands)

9.1.11.1 Mexico: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.1.11.2 Mexico: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.1.11.3 Mexico: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2 Europe: 3D Printed Drugs Market

9.2.1 Overview

9.2.2 Europe: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.3 Europe: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.4 Europe: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2.5 Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

9.2.6 Germany: 3D Printed Drugs Market

9.2.6.1 Germany: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.6.2 Germany: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.6.3 Germany: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2.7 United Kingdom: 3D Printed Drugs Market

9.2.7.1 United Kingdom: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.7.2 United Kingdom: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.7.3 United Kingdom: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2.8 France: 3D Printed Drugs Market

9.2.8.1 France: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.8.2 France: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.8.3 France: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2.9 Italy: 3D Printed Drugs Market

9.2.9.1 Italy: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.9.2 Italy: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.9.3 Italy: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.2.10 Spain: 3D Printed Drugs Market

9.2.10.1 Spain: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.2.10.2 Spain: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.2.10.3 Spain: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3 Asia Pacific: 3D Printed Drugs Market

9.3.1 Overview

9.3.2 Asia Pacific: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.3 Asia Pacific: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.4 Asia Pacific: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3.5 Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

9.3.6 China: 3D Printed Drugs Market

9.3.6.1 China: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.6.2 China: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.6.3 China: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3.7 Japan: 3D Printed Drugs Market

9.3.7.1 Japan: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.7.2 Japan: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.7.3 Japan: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3.8 India: 3D Printed Drugs Market

9.3.8.1 India: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.8.2 India: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.8.3 India: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3.9 South Korea: 3D Printed Drugs Market

9.3.9.1 South Korea: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.9.2 South Korea: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.9.3 South Korea: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.3.10 Australia: 3D Printed Drugs Market

9.3.10.1 Australia: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.3.10.2 Australia: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.3.10.3 Australia: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.4 Middle East & Africa: 3D Printed Drugs Market

9.4.1 Overview

9.4.2 Middle East & Africa: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.4.3 Middle East & Africa: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.4.4 Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

9.4.5 Saudi Arabia: 3D Printed Drugs Market

9.4.5.1 Saudi Arabia: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.4.5.2 Saudi Arabia: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.4.5.3 Saudi Arabia: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.4.6 South Africa: 3D Printed Drugs Market

9.4.6.1 South Africa: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.4.6.2 South Africa: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.4.6.3 South Africa: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.4.7 UAE: 3D Printed Drugs Market

9.4.7.1 UAE: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.4.7.2 UAE: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.4.7.3 UAE: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.5 South and Central America: 3D Printed Drugs Market

9.5.1 Overview

9.5.2 South and Central America: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.5.3 South and Central America: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.5.4 South and Central America: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.5.5 South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

9.5.6 Brazil: 3D Printed Drugs Market

9.5.6.1 Brazil: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.5.6.2 Brazil: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.5.6.3 Brazil: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

9.5.7 Argentina: 3D Printed Drugs Market

9.5.7.1 Argentina: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)

9.5.7.2 Argentina: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)

9.5.7.3 Argentina: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)

10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. 3D Printed Drugs Market –Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 GlaxoSmithKline plc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Aprecia Pharmaceuticals, LLC.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 AstraZeneca

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 Key Developments

12.4 FabRx Ltd

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Merck KGaA

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Cycle Pharmaceuticals

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Tvasta

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 MSD

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2027 (USD Thousands)

Table 2. North America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 3. North America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2027 (USD Thousands)

Table 4. North America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 5. US 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2027 (USD Thousands)

Table 6. US 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 7. US 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2027 (USD Thousands)

Table 8. US 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 9. Canada 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 10. Canada 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 11. Mexico 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 12. Mexico 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 13. Europe 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 14. Europe 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 15. Germany 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 16. Germany 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 17. United Kingdom 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 18. United Kingdom 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 19. France 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 20. France 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 21. Italy 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 22. Italy 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 23. Spain 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 24. Spain 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 25. Asia Pacific 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 26. Asia Pacific 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 27. China 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 28. China 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 29. Japan 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 30. Japan 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 31. India 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 32. India 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 33. South Korea 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 34. South Korea 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 35. Australia 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 36. Australia 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 37. Middle East & Africa 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 38. Middle East & Africa 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 39. Saudi Arabia 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 40. Saudi Arabia 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 41. South Africa 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 42. South Africa 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 43. UAE 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 44. UAE 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 45. South and Central America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)

Table 46. South and Central America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 47. Brazil 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 48. Brazil 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 49. Argentina 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)

Table 50. Argentina 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)

Table 1. Organic Developments Done By Companies

Table 2. Inorganic Developments Done By Companies

Table 3. Glossary of Terms, 3D Printed Drugs market

LIST OF FIGURES

Figure 1. 3D Printed Drugs Market Segmentation

Figure 2. 3D Printed Drugs Segmentation, By Region

Figure 3. Global 3D Printed Drugs Market Overview

Figure 4. The Tablets Segment Held Largest Share Of Dosage Forms Segment In 3D Printed Drugs Market (US$ Thousands)

Figure 5. North America Is Expected to Show Remarkable Growth During the Forecast Period (US$ Thousands)

Figure 6. Global 3D Printed Drugs Market, By Geography (US$ Thousands)

Figure 7. Global 3D Printed Drugs Market, Industry Landscape

Figure 8. North America PEST Analysis

Figure 9. Europe PEST Analysis

Figure 10. Asia Pacific PEST Analysis

Figure 11. Middle East & Africa PEST Analysis

Figure 12. South & Central America PEST Analysis

Figure 13. 3D printed drugs market impact analysis of driver and restraints

Figure 14. Global 3D Printed Drugs Market– Revenue Forecast And Analysis – 2019- 2027 (US$ Mn)

Figure 15. Market Positioning Of Key Players In Global 3D Printed Drugs Market

Figure 16. 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035 (%)

Figure 17. Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2027 (US$ Thousands)

Figure 18. Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 19. Capsules: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 20. Multi Drug Implant: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 21. Nanoparticles: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 22. Solutions: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 23. Other Dosage Forms: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 24. 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)

Figure 25. Inkjet Printing: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

Figure 26. Direct Write: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

Figure 27. Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2027 (US$ Thousands)

Figure 28. Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)

Figure 29. Thermal Inkjet: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 30. Fused Deposition Modelling:3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 31. Powder Bed Printing: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 32. Stereolithography: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 33. Semi Solid Extrusion (SSE): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)

Figure 34. North America: 3D Printed Drugs Market, by Key Country – Revenue (2019) (USD Thousands)

Figure 35. North America: 3D Printed Drugs Market, by Key Country – Revenue (2035) (USD Thousands)

Figure 36. North America 3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)

Figure 37. North America 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 38. North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)

Figure 39. US3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)

Figure 40. US3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 41. Canada3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 42. Mexico3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 43. Europe: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)

Figure 44. Europe3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 45. Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

Figure 46. Germany 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 47. United Kingdom3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 48. France3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 49. Italy3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 50. Spain3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 51. Asia Pacific: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)

Figure 52. Asia Pacific3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 53. Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

Figure 54. China 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 55. Japan3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 56. India3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 57. South Korea3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 58. Australia3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 59. Middle East & Africa: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)

Figure 60. Middle East & Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 61. Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

Figure 62. Saudi Arabia 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 63. South Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 64. UAE3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 65. South and Central America: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)

Figure 66. South and Central America3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 67. South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)

Figure 68. Brazil 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 69. Argentina3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)

Figure 70. Impact of COVID-19 Pandemic In North American Country Markets

Figure 71. Impact of COVID-19 Pandemic In European Country Markets

Figure 72. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

Figure 73. Impact Of COVID-19 Pandemic In North American Country Market

Figure 74. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - 3D Printed Drugs Market

  1. APRECIA PHARMACEUTICALS, LLC
  2. FabRx LTD
  3. Cycle Pharmaceuticals
  4. GLAXOSMITHKLINE PLC.
  5. ASTRAZENECA
  6. Tvasta
  7. Merck KGGA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to 3D Printed Drugs Market